This lecture will review the past and current landscape of anti-fibrotic drugs and the challenges the field is facing, and propose new solutions.
42% of deaths in the developed countries are due to some kind of fibrotic disease. Despite efforts over the last 50 years, there is still no cure and treatment options are limited.
Fibrosis occurs when the body produces too much scar tissue, doing more harm than good. It can affect any organ and can be deadly.
This lecture will review the past and current landscape of anti-fibrotic drugs, the challenges the field is facing and propose new solutions.
He leads the Fibrosis Research Group which focuses on discovery and development of novel anti-fibrotic drugs through phenotypic screening assays.
This event will be taking place in Queens 101 at Anglia Ruskin University, Chelmsford.